(Reuters) - Israeli drugmaker Kamada Ltd said its rabies therapy was found as effective as a reference drug in a large trial and it would file for a U.S. approval for the therapy by mid-2016.
http://ift.tt/xePdMM
from Reuters: Health News
via
animenewspro
Aucun commentaire:
Enregistrer un commentaire